The Jersey Biopharma Council (the Council)  is an industry body representing
organisations and individuals operating in Jersey’s regulated biopharmaceutical sector.

The Council supports the development of Jersey’s biopharmaceutical sector by:

• facilitating dialogue between industry and policymakers
• encouraging high operational and governance standards
• providing a coordinated industry perspective on sector development

The Council does not act as a regulator. Regulatory oversight remains the responsibility of the relevant authorities.

Jersey’s regulated biopharmaceutical sector includes organisations and individuals involved in the cultivation, processing and development of regulated biopharmaceutical products.

The sector operates within an established licensing framework designed to ensure that activities are conducted responsibly and in accordance with regulatory requirements.

The sector currently includes regulated medicinal cannabis cultivation and pharmaceutical development, as well as research into other therapeutic compounds, including psilocybin. The Council’s scope extends to all lawful and regulated biopharmaceutical activity in Jersey as the sector develops.

Companies operating in the sector must obtain the appropriate licences and comply with regulatory requirements established by the relevant authorities.

These requirements are designed to ensure that operations meet strict standards relating to safety, compliance and responsible conduct.

Regulatory oversight in Jersey is the responsibility of the relevant Jersey authorities. The Jersey Biopharma Council is not a regulator and does not have any role in the licensing or enforcement process.

Membership of the Jersey Biopharma Council is open to individuals and organisations that are lawfully authorised or professionally qualified to operate within the biopharmaceutical sector in Jersey.

This includes holders of licences or qualifications for cultivation, research, manufacturing, or other regulated activities. Both corporate and individual membership is available.

The Council represents its member organisations and provides a forum through which industry participants can collaborate and engage with policymakers.

Membership may expand as the sector develops.

No. The Jersey Biopharma Council is an industry body made up of companies operating within the sector.

The Council works constructively with government and regulators but does not form part of government.

The production and development of certain biopharmaceutical products is permitted in Jersey under a regulated licensing framework.
Companies operating in the sector must obtain the appropriate licences and comply with regulatory requirements established by the relevant authorities. These requirements are designed to ensure that activities are conducted responsibly and in accordance with applicable laws and standards.

The sector represents a developing area of economic activity that may contribute to Jersey’s broader economic diversification.

Companies operating in the sector bring specialist expertise and investment to the Island, while operating within a regulated framework designed to maintain high standards and protect Jersey’s reputation.

The long-term development of the sector will depend on maintaining regulatory credibility and responsible industry practices.

Medicinal cannabis refers to cannabis-derived products that are produced, tested and prescribed for therapeutic purposes under a regulated framework. Members of the Jersey Biopharma Council are involved only in the regulated cultivation and export of medicinal cannabis and related products.

Enquiries relating to the Jersey Biopharma Council or the Island’s regulated biopharmaceutical sector can be made through the contact details provided on the Contact page.